Exciting times for cytomegalovirus (CMV) vaccine development: Navigating the pathways toward the goal of protecting infants against congenital CMV infection

Mark R. Schleiss; Don J. Diamond

doi:10.3390/vaccines8030526

Exciting times for cytomegalovirus (CMV) vaccine development: Navigating the pathways toward the goal of protecting infants against congenital CMV infection

Mark R. Schleiss, Don J. Diamond

Pediatric Infectious Diseases

Research output: Contribution to journal › Editorial › peer-review

12 Scopus citations

Abstract

The congenital transmission of cytomegalovirus (cCMV) is the most common infectious cause of disability in children in the developed world, and probably globally [...].

Original language	English (US)
Article number	526
Pages (from-to)	1-4
Number of pages	4
Journal	Vaccines
Volume	8
Issue number	3
DOIs	https://doi.org/10.3390/vaccines8030526
State	Published - Sep 14 2020

Bibliographical note

Funding Information:
Support for Mark R. Schleiss from R01 HD098866 and R01 HD079918. Don J. Diamond is partially supported by NIH-U19 AI128913, NIH-P01 CA111412, and NIH-R01 CA181045. This work was also supported by the University of South Carolina’s Disability Research and Dissemination Center (DRDC) through its Cooperative Agreement (Number 6U19DD001218) with the Centers for Disease Control and Prevention (CDC). Acknowledgments: Support from the Minnesota American Legion and Auxiliary is acknowledged.

Funding Information:
Funding: Support for Mark R. Schleiss from R01 HD098866 and R01 HD079918. Don J. Diamond is partially supported by NIH-U19 AI128913, NIH-P01 CA111412, and NIH-R01 CA181045. This work was also supported by the University of South Carolina’s Disability Research and Dissemination Center (DRDC) through its Cooperative Agreement (Number 6U19DD001218) with the Centers for Disease Control and Prevention (CDC).

Publisher link

10.3390/vaccines8030526

Find It

Find It at U of M Libraries

Cite this

@article{04c24b9aeef0491eb73e0172f92aa3fb,

title = "Exciting times for cytomegalovirus (CMV) vaccine development: Navigating the pathways toward the goal of protecting infants against congenital CMV infection",

abstract = "The congenital transmission of cytomegalovirus (cCMV) is the most common infectious cause of disability in children in the developed world, and probably globally [...].",

author = "Schleiss, {Mark R.} and Diamond, {Don J.}",

note = "Funding Information: Support for Mark R. Schleiss from R01 HD098866 and R01 HD079918. Don J. Diamond is partially supported by NIH-U19 AI128913, NIH-P01 CA111412, and NIH-R01 CA181045. This work was also supported by the University of South Carolina{\textquoteright}s Disability Research and Dissemination Center (DRDC) through its Cooperative Agreement (Number 6U19DD001218) with the Centers for Disease Control and Prevention (CDC). Acknowledgments: Support from the Minnesota American Legion and Auxiliary is acknowledged. Funding Information: Funding: Support for Mark R. Schleiss from R01 HD098866 and R01 HD079918. Don J. Diamond is partially supported by NIH-U19 AI128913, NIH-P01 CA111412, and NIH-R01 CA181045. This work was also supported by the University of South Carolina{\textquoteright}s Disability Research and Dissemination Center (DRDC) through its Cooperative Agreement (Number 6U19DD001218) with the Centers for Disease Control and Prevention (CDC).",

year = "2020",

month = sep,

day = "14",

doi = "10.3390/vaccines8030526",

language = "English (US)",

volume = "8",

pages = "1--4",

journal = "Vaccines",

issn = "2076-393X",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "3",

}

TY - JOUR

T1 - Exciting times for cytomegalovirus (CMV) vaccine development

T2 - Navigating the pathways toward the goal of protecting infants against congenital CMV infection

AU - Schleiss, Mark R.

AU - Diamond, Don J.

N1 - Funding Information: Support for Mark R. Schleiss from R01 HD098866 and R01 HD079918. Don J. Diamond is partially supported by NIH-U19 AI128913, NIH-P01 CA111412, and NIH-R01 CA181045. This work was also supported by the University of South Carolina’s Disability Research and Dissemination Center (DRDC) through its Cooperative Agreement (Number 6U19DD001218) with the Centers for Disease Control and Prevention (CDC). Acknowledgments: Support from the Minnesota American Legion and Auxiliary is acknowledged. Funding Information: Funding: Support for Mark R. Schleiss from R01 HD098866 and R01 HD079918. Don J. Diamond is partially supported by NIH-U19 AI128913, NIH-P01 CA111412, and NIH-R01 CA181045. This work was also supported by the University of South Carolina’s Disability Research and Dissemination Center (DRDC) through its Cooperative Agreement (Number 6U19DD001218) with the Centers for Disease Control and Prevention (CDC).

PY - 2020/9/14

Y1 - 2020/9/14

N2 - The congenital transmission of cytomegalovirus (cCMV) is the most common infectious cause of disability in children in the developed world, and probably globally [...].

AB - The congenital transmission of cytomegalovirus (cCMV) is the most common infectious cause of disability in children in the developed world, and probably globally [...].

UR - http://www.scopus.com/inward/record.url?scp=85090912583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090912583&partnerID=8YFLogxK

U2 - 10.3390/vaccines8030526

DO - 10.3390/vaccines8030526

M3 - Editorial

C2 - 32937764

AN - SCOPUS:85090912583

SN - 2076-393X

VL - 8

SP - 1

EP - 4

JO - Vaccines

JF - Vaccines

IS - 3

M1 - 526

ER -

Exciting times for cytomegalovirus (CMV) vaccine development: Navigating the pathways toward the goal of protecting infants against congenital CMV infection

Abstract

Bibliographical note

Publisher link

Find It

Other files and links

Fingerprint

Cite this